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ABSTRACT
T
he inbred mouse is an invaluable model for human
biology and disease. Nevertheless, when considering
genetic mechanisms of variation and disease, it is
important to appreciate the signiﬁcant differences in the
spectra of spontaneous mutations that distinguish these
species. While insertions of transposable elements are
responsible for only ;0.1% of de novo mutations in humans,
the ﬁgure is 100-fold higher in the laboratory mouse. This
striking difference is largely due to the ongoing activity of
mouse endogenous retroviral elements. Here we brieﬂy
review mouse endogenous retroviruses (ERVs) and their
inﬂuence on gene expression, analyze mechanisms of
interaction between ERVs and the host cell, and summarize
the variety of mutations caused by ERV insertions. The
prevalence of mouse ERV activity indicates that the genome
of the laboratory mouse is presently behind in the ‘‘arms
race’’ against invasion.
Introduction
The activity of transposable elements (TEs) places a
variable mutational load upon their host species [1–3]. In
species such as Drosophila, TEs comprise approximately 10%
of heterochromatic [4] and only 2%–3% of euchromatic DNA
[4,5] but cause over 50% of de novo mutations [6]. In contrast,
nearly half of the human genome is TE-derived but de novo
disease-causing insertions are rare [7,8]. TE activity in the
laboratory mouse falls in the middle of these two extremes
[8,9], largely because of the activity of endogenous
retroviruses (ERVs) and other elements with long terminal
repeats (LTRs), which together make up 8%–10% of the
genome [7,9–12] (Box 1). A striking difference between the
mouse and the human repertoire of ERVs/LTR elements is
that the mouse contains many ‘‘active’’ LTR retroelements
and a few potentially infectious ERVs that are closely related
to exogenous mouse retroviruses [9,13]. Unlike in inbred
mice, infectious human ERVs have not been described, no
new insertions have been found, and there are no ERVs
closely related to human exogenous retroviruses [10,11,14]. In
addition to LTR elements, the major classes of
retrotransposons in mammals are the non-autonomous short
interspersed elements (SINEs) and the autonomous long
interspersed elements (LINEs) [7,9,12]. The
retrotransposition and genomic effects of these non-LTR
retroelements have been extensively discussed in a number of
recent reviews [2,15,16].
Since the mouse is widely used as a disease model, it is
important to understand the mutagenic events affecting this
species and how they differ from those in humans. This
article examines mouse ERVs and other LTR retroelements,
focusing on insertional mutagenesis of the germ line. For the
purposes of this review, LTR retroelements, which amplify via
intracellular retrotransposition, and true exogenous
retroviruses, which amplify by extracellular infections and
retrotransposition, will be considered together as ‘‘ERVs’’ as
they have a common evolutionary origin [13]. We discuss
mutational mechanisms of different families of ERVs,
illustrating signiﬁcant differences in their effects on genes.
We also discuss host responses to curtail ERV activity and, in
some cases, to adopt ERVs for normal cell functions. Finally,
we present the view that inbred mice are in a transitory state
in which ERVs are not at equilibrium with their host genome.
Prevalence of ERV-Induced Mouse Insertional
Mutations
Present-day activities are markedly different between
human and mouse ERVs. A recent review lists 48 TE insertion
mutations in human [17], and estimates of the frequency of
novel human TE insertions range from one
retrotransposition per 8–33 births [2,18–20], all of them due
to L1-mediated non-LTR retrotransposons (reviewed in
[21,22]). Given that ;47,000 mutant alleles have been
characterized (according to the Human Gene Mutation
Database [http://www.hgmd.cf.ac.uk/]; August 2005), these
numbers suggest that ;0.1% of human spontaneous
mutations are due to TE insertions, but none are due to ERV
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insertions have been reported in mice (reviewed in [22,23]).
However, the ongoing activity of ERVs accounts for the
majority of new insertional mutations in the mouse. To
provide a current estimate of the fraction of spontaneous
mutations due to ERV insertion, we tabulated all documented
cases and found 63 (Table S1). The Mouse Genome
Informatics database (http://www.informatics.jax.org/) lists
1,489 spontaneous mutant alleles (as of August 2005). After
removing unannotated cases and numerous non-independent
entries and revertants derived from the nonagouti a allele (Box
2), 519 spontaneous alleles with an annotated molecular
mechanism remained. This list included 55 of our 63 ERV
insertion mutations. Taken at face value, these ﬁgures suggest
that 10%–12% of all mutations are due to ERV insertions, a
fraction very similar to previously reported estimates of
10%–15% based on lower numbers [22,23]. Reversion of
ERV-induced mutations has also been observed at a few loci
due to LTR–LTR recombination (Box 2). It should be noted
that the 10%–15% ﬁgure is likely an underestimate because
of ascertainment bias. For example, point mutations in
coding regions will be more readily detected than ERV
insertions in introns or outside gene borders. Regardless of
the precise ﬁgure, ERV activity in inbred mice is dramatically
higher than in modern humans.
Most ERVs are highly transcribed during early zygotic
divisions and in germ cells, resulting in an increased
likelihood of new heritable proviral integrations (Box 3).
Although genomic copy numbers of murine leukemia virus
(MLV) are low (see Box 1), this family is the most active mouse
ERV on a per provirus basis. New MLV provirus acquisitions
are found in 2%–75% of the progeny in the highly
susceptible SWR/J-RF/J hybrid mice [24–26]. AKR mice appear
to gain one new ecotropic MLV provirus every 50–100
generations [13]. Five germ line mutations or strain variants
due to insertions of MLV have been well characterized in
other lab strains (Table S1). The somatic effects of MLV, as
well as mouse mammary tumor virus, in activating oncogenes
via insertional mutagenesis are well known [27]. Indeed,
mapping common retroviral integration sites in mouse tumor
systems has proven a powerful strategy to identify new genes
involved in cancer [28,29].
Intracisternal A particle (IAP) and Early Transposon (ETn)/
MusD elements are present in much higher copy numbers
than MLVs (Box 1) and are responsible for the majority of
ERV-induced de novo germ line mutations (Tables 1 and S1).
In addition, IAP elements are frequent insertional mutagens
in somatic cells, particularly in leukemia, plasmocytoma, and
myeloma cell lines, and can activate oncogenes or cytokine
genes [30]. Notably, very few new ETn insertions have been
Box 1. Classification of Mouse ERVs
A plethora of ERV families exist in the mouse and are grouped into
three major classes (class I, II, and III) [9,13,80]. ERVs with infectious
counterparts, namely MLV and mouse mammary tumor virus, have
been studied for decades and are the subject of many excellent
reviews [13,81,82]. Here we focus on the less well appreciated class II
IAP and ETn elements, which account for the majority of
characterized germ line insertional mutations, and briefly touch on
representatives of other classes.
Class I retroviruses. The class I/type C/gammaretroviruses,
composing about 0.7% of the genome [9] and grouped based on
similarity to MLV [13], were first isolated from lymphomas of AKR
mice [83]. MLV entered the germ line of mice approximately 1.5
million years ago and its copy number ranges from 25 to 70
depending on the mouse strain. MLV proviruses are subdivided
based on their host ranges determined by their env genes, but only
a few encode replication-competent viruses [13,84]. Class I also
includes several other families, but it is unclear if any have fully
coding-competent members [13].
Class II retroviruses. The prototype of the much more numerous
class II/types B and D/betaretroviral group, composing about 3% of
the genome [9], is mouse mammary tumor virus [13]. A wide variety
of other mouse betaretroviral ERV families also exist, some of which
retain coding capacity and appear to have entered the genome
quite recently [80,85].
One of the most extensively studied noninfectious families of
ERVs in the mouse is the IAP family. Though there is variation in
copy numbers between different mouse strains, about 700 full-
length and 300 partially deleted elements are present in the haploid
mouse genome. Type I elements encompass full-length members as
well as four deleted classes [37]. Of these, the ID1 subclass, which
has a 1.9-kb deletion in gag-pol, is the most abundant deleted form
in the mouse genome and is also responsible for the majority of IAP
insertional mutations [32,33]. Type II elements differ from type I
elements by a characteristic 500-bp length difference and only
comprise partially deleted members [37]. IAP elements were
thought to lack an env gene until about 200 env-containing
elements were discovered [86].
The other major family of active mouse LTR elements are ETns,
first described as a family of non-coding sequences transcribed
during early embryogenesis [87]. ETn RNA levels are significantly
elevated and restricted to certain tissues during embryonic days
3.5[87]to13.5[88].Two majorsubtypesofETn elements,IandII,
differ in the 3’ portion of the LTR and a 5’ internal segment. As
withIAPelements,copynumberslikelyvarybetweenstrains,but
the February 2002 release of the C57BL/6 genome has ;200 ETnI
and ;40 ETnII elements [35]. Although ETnI elements are more
numerous,ETnIIelementsarecurrentlymoreactive[31].Thelack
of coding potential in ETn elements raised questions as to how
they could retrotranspose, but it is now clear that a related
coding-competent family of endogenous betaretroviruses,
termed MusD [89], that share nearly identical LTRs with ETns,
provide the proteins necessary for ETn retrotransposition [36].
No MusD element has an env-related sequence, suggesting
amplification exclusively via retrotransposition.
Class III retroviruses. Mouse class III elements, which may
i n c l u d es o m ea c t i v eE R V s ,c o n s i s to ft h eM u E R V - Lf a m i l y ,w h i c h
encompasses up to 200 proviral copies of about 7.5 kb per
haploid genome [90] and different subgroups of the highly
repetitive non-autonomous ORR1 and MT MaLR elements [91].
Class III elements compose approximately 5.4% of the genome
[9], significantly contribute to the early mouse transcriptome
[52], and affect gene regulation (Box 4). However, only one
mutation due to insertion of a class III MaLR element has been
documented (Table S1).
Many mouse and human ERVs and solitary LTRs remain
essentially unstudied, except for their annotation in the Repbase
database of repetitive sequences [92]. Since such annotations
are often based on incomplete information, they should be
viewed with caution [85].
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expression patternorlimited expression of coding-competent
MusD elements, required for ETn retrotransposition.
Genetic Background and ERV Subtype Influence on
Insertion Probability
Not all mouse strains are equally susceptible to ERV
insertions. Most of the IAP insertions have occurred in C3H/
HeJ (Tables 1 and S1), and nearly all of these cases are of the
IAP subtype ID1 [32,33]. It seems likely that one or a small
number of ID1 IAP elements are active in this strain, possibly
because of a favorable genomic context or escape from host
suppression mechanisms (see below). The ID1 subtype,
however, requires complementation in trans from coding-
competent IAP elements [34], so the latter must also be
expressed. A speciﬁc strain bias for ETn insertions is not as
obvious, although six mutations have occurred in A/J mice and
two in each of two other infrequently used strains (SELH/Bc
and MRL/MpJ) (Table S1). As with IAP elements, this suggests
that some strains harbor more ‘‘active’’ elements and/or allow
more ETn or MusD expression. Where sufﬁcient sequence is
available, it has been found that most ETn insertions are of a
particular structural subtype, ETnII-b, and are nearly
identical, suggesting very few currently active elements ([35];
unpublished data). A very deﬁnite strain bias has been
observed for germ line movement of MLVs, with AKR and
SWR/J-RF/J mice being highly active strains (reviewed in [13])
(see Box 3). One of the explanations for such selective activity
in particular strains may be the presence of a single highly
transcribed master element in a favorable genomic context, as
appears to be the case for AKR mice. The other explanation is
the difference in host suppression factors, such as methylation
levels and the presence of virus-suppressing loci. One long-
studied locus involved in suppression of MLV and a number of
other ERVs is Fv1 (see below).
As mentioned above, most de novo insertions of IAP and
ETn elements are those of defective sequences lacking full
coding potential. This fact is curious, given that, in assay
systems, coding-competent IAP and MusD elements
retrotranspose much more efﬁciently when proteins and
retrotransposing RNA are encoded by the same template (cis
preference) [34,36]. Expression patterns of defective and full-
length IAP elements vary widely in different cells [30,32,37],
but the ID1 deleted subtype is preferentially expressed in
acute myeloid leukemia cell lines derived from C3H/HeJ mice,
despite being present at lower genomic numbers than full-
length forms [32]. Non-coding ETnII elements are transcribed
at a much higher level than their coding-competent MusD
relatives [35], probably explaining their higher likelihood to
retrotranspose. Indeed, among the 23 characterized
mutagenic ETn/MusD insertions, only two have been reported
as MusD (Table S1). However, it is unclear why transcripts
from defective elements would predominate in vivo. Possibly
they are less likely to be recognized as retroviral elements and
to be repressed by host cell silencing machinery.
Mutagenic Mechanisms of ERV Insertions
Most commonly, germ line mutations due to ERV
insertions occur in an intron, disrupting gene expression by
causing premature polyadenylation, aberrant splicing, or
ectopic transcription driven by the ERV LTR (Tables 1 and
S1). In some cases, small amounts of normal gene transcripts
and protein can still be detected. While the number of
characterized MLV-induced mutations is too small to
perceive general trends, IAP and ETn elements show
signiﬁcant differences in their effects on genes (Figure 1). For
ETn insertions, the most commonly reported defect is
Box 2. Reversion of ERV-Induced Mutations
In a few instances, reversion to a wild-type phenotype occurs
among mice carrying ERV insertional mutations. The mechanism of
reversioninvolvesdeletionofinternalERVsequencesviahomologous
recombination between the 5’ and the 3’ LTRs of the provirus in the
parental germ line, leaving behind a solitary LTR. Such generation of
solitary LTRs has been noted in early studies on MLV [93], and this
mechanism has been efficient throughout evolution. Indeed, solitary
LTRs are typically present in much higher copy numbers than full
proviral forms and make up the bulk of retroviral material in the
mouse and human genomes [9,11]. In the case of the hairless
mutation [94] and the dilute coat color mutation [95], both of which
are caused by aberrant splicing due to an MLV integration into the
intron, reversion to wild-type occurs via generation of a solitary LTR.
Germ line reversions of the dilute mutation occur at a frequency of
3.9–4.5 x10
6 events per gamete[96], and one somatic revertant,
chimeric for about 50% of reverted cells, was encountered, with the
frequency of somatic reversion estimated at 93107 per animal
analyzed [96]. Occasionally, reversions can result in diverse
phenotypes because of expression of different forms of transcripts.
Such is the case with the nonagouti a allele, which encompasses an
insertion of a 5.5-kb VL30 element containing 5.5 kb of additional
internal sequence flanked by 526-bp direct repeats. By means of
homologous recombination, a can revert to two dominant agouti
alleles, black-and-tan (a[t]), containing only the VL30 element with a
singleinternal526-bprepeat,and thewhite-bellied agouti(Aw),which
only has a solitary VL30 LTR [97]. There is no published evidence of
otherERV-inducedmutationsrevertingtowild-type,perhapsbecause
of the difficulties associated with breeding the mutant animals, the
time span required to detect reversions, and, for the somatic
revertants, restricted tissues where the reversion could be detected.
Table 1. Overview of IAP and ETn Mutagenic Germ Line
Insertions
Characteristic Family
IAP ETn/MusD
Genomic copy number ;1,000 300–400
Number of mutagenic insertions
a 32 23
Strain bias C3H (.50%) A/J (;30%)
Active subtype IAP ID1 ETnII-b
Promoter effects Yes (antisense) No
Polyadenylation and splicing effects Common Common
Somatic insertions Common Rare
Intronic orientation relative
to affected gene
Mixed Sense (15/16 cases)
aCharacterized new germ line insertions, including strain variants. For complete details, see Table S1.
DOI: 10.1371/journal.pgen.0020002.t001
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aberrant splicing due to a few commonly used cryptic splice
signals (Figures 1 and 2A). IAP insertions within introns also
typically cause aberrant splicing but use a wider variety of
cryptic splice signals. In addition, compared to ETns, fewer
cases of premature polyadenylation within IAP elements are
well documented (Figure 1), but, in many cases, all aberrant
gene transcripts have not been well characterized.
A striking difference between the effects of IAP and ETn
elements is their tendency to drive ectopic gene expression
(Figure 1). For IAP elements, nine cases of LTR-driven gene
expression have been reported. Interestingly, eight of these
nine cases are driven from an antisense promoter located in
the 5’ IAP LTR (Figure 2B; Tables 1 and S1). Many of the
mutant alleles caused by IAP LTR-driven gene expression
show variable expressivity among genetically identical mice
and have therefore been termed metastable epialleles [38].
The variable expressivity is due to stochastic establishment of
the methylation state of the 5’ LTR. If the LTR is mostly
methylated, its promoter is inactive and little or no effect on
the gene is observed. However, if the LTR is unmethylated, its
promoter drives ectopic gene expression, resulting in the
Box 4. Adoption of ERVs to Serve the Host
Although the vast majority of TE and ERV insertions are selectively
neutral, allowing them to drift to fixation, or detrimental and subject
to negative selection, such elements can occasionally be co-opted
by the host to serve important cellular functions [2,3,71,102]. For
example, as mentioned in the text, endogenous viral loci can play a
role in repelling exogenous retroviral infections (Table 2). Ancient
ERVs may also have been co-opted to function in placental
development in humans [103,104] and mice [105], prompting the
suggestion that expression of different ERVs is partly responsible for
the great diversity of mammalian placental structures [106].
A growing number of studies have shown that LTR elements are
particularly well suited to donation of enhancers or promoters and, if
fixed, can assume roles in gene regulation. Many examples of
mammalian genes regulated by ERVs/LTRs or other TEs have been
reported [71,74,107–110], such as the mouse Slp (sex-limited protein)
gene, which has acquired male-specific expression due to a MuRRS
ERV that provides an enhancer [111], and the CYP19 gene, encoding a
key enzyme in estrogen biosynthesis, which has high expression in
humanandprimateplacentaduetoanalternativepromoterprovided
by an ancient LTR [74]. A recent study documenting ERVs present in
chimpanzee but not human found that several such elements were
associated with genes differentially expressed in the two species
[112], raising the possibility that ERVs and other TEs may be critical in
driving speciation, as has been discussed by others [2,3,71,102].
Most ERV LTRs seem to be extremely powerful, ready-made
promoters active during early embryogenesis and in the germ line,
and recent work has fueled speculation that LTR retroelements
could play a role in expression of genes essential for early
development. Knowles and co-workers reported that about 13% of
cDNAs from full-grown mouse oocytes contained retroviral
sequences, the majority of which were derived from the poorly
understood class III MT MaLR family [52], but by the two-cell stage,
transcripts of another class III family, MuERV-L, started to
predominate [52,113]. Notably, MT, MuERV-L, and some other LTRs
were found to act as alternative promoters for subsets of host genes
in full-grown oocytes and cleavage-stage embryos, apparently
controlling synchronous, developmentally regulated expression of
these genes [52]. An independent study reported that blocking
MuERV-L expression inhibits embryonic development to the four-
cell stage [113]. Such findings have prompted the proposal that
differential gene expression driven by LTRs may trigger sequential
reprogramming and genome remodeling during embryonic
development [52]. This idea is intriguing, but since LTR
retrotransposon families and insertion patterns are generally not
conserved across divergent species, it is difficult to envisage a
scenario in which such elements evolved to play a critical role in
common developmental processes. It is easier to imagine LTRs/TEs
being involved in species-specific processes. Nevertheless, it is clear
that McClintock’s original theory of TEs as ‘‘controlling elements’’
[114] and Britten and Davidson’s postulation of repetitive elements
as regulatory units [115], views that have been little appreciated for
decades, are now gaining increasing attention.
Box 3. Dynamics of ERV Expression and Transcriptional
Restriction
Acquisition of new heritable proviruses requires expression in the
germ line and, indeed, transcription of ERVs in different species is
elevated in germ line cells, early embryo, and placenta compared to
adult or differentiated tissues [98]. Active transcription during early
developmental stages is advantageous to ERVs, since it increases the
probability of proviral integrations likely to contribute to the germ
line and be inherited by the next generation. High transcriptional
activity of ERVs in early embryogenesis is partly due to lower levels
of suppressive methylation, but expression profiles do not coincide
exactly with the patterns of global genomic de- and remethylation
[99] and are likely also the result of changing transcription factor
repertoire during development.
In AKR mice, a high-leukemic mouse strain, MLV transcripts are
detected at high levels in the embryo and throughout the life of the
animal, likely originating from one ancestral provirus in this strain
[13]. In low-leukemic mouse strains, such as BALB/c, C3H/He, and
C57BL/6, MLV proviruses are transcribed at significantly lower or
undetectable levels (reviewed in [82]). Transcript levels of ETn and
IAP elements are also highest during early embryogenesis
[37,87,88,98]. While IAP elements are expressed in many mouse
tumors and cell lines [37], expression of ETns is more restricted,
elevated only in undifferentiated embryonic carcinoma and ES cells,
as well as in primary acute myeloid leukemia cells [100]. Though IAP
transcripts are detectable in some normal adult tissues and cell
types, such as thymus and activated splenic B cells (for review see
[37]), a reporter gene system in transgenic mice found IAP promoter
activity to be restricted to undifferentiated spermatogonia [101].
This finding suggests that IAP transcripts produced in differentiated
somatic tissues or tumor cells may initiate from only a very limited
number of elements in favorable genomic contexts or may be
influenced by other genes. Indeed, in most studies on ERV
expression, it is unclear how many individual elements contribute to
the transcript pool, a fact that limits firm conclusions on
transcriptional activity of these large families.
Time-specific restrictions placed on ERV transcription, limited
largely to a narrow window of early embryogenesis, are suggestive of
extremely tight regulation imposed by complex mechanisms of the
host genome in an effort to prevent somatic insertional mutagenesis.
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by Whitelaw and coworkers, who have proposed the
intriguing theory that phenotypic variation in mammals
could in part be due to incomplete and variable silencing of
retrotransposons in somatic cells [39].
It is unclear why no instances of ETn-promoted ectopic
gene expression have been observed, but the lack of such cases
could be explained by inactivity of the ETn LTR promoter in
somatic cells due to heavy methylation or lack of necessary
transcription factors. Expression studies (Box 3) indicate that
at least some IAP elements are transcribed in various cell
types, a property that would increase the probability of such
elements providing promoter function. It is possible that the
presence of the cryptic antisense promoter in the IAP LTR
also increases the likelihood that an IAP element 5’ of a gene
will provide promoter function (Figure 2B).
Host Silencing Mechanisms
Transcriptional gene silencing. To guard against harmful
genomic consequences of ERVs and other TEs, an arsenal of
cellular defense strategies has evolved to counteract their
ampliﬁcation (Figure 3; Table 2). Transcriptional gene
silencing is a principle mechanism for controlling TEs in a
broad range of species including mammals, ﬂowering plants,
and those fungi whose genomes contain m
5C [40]. The best-
documented mechanism, DNA methylation of promoters, can
directly impede access of transcription factors or lead to an
inactive form of chromatin at target loci [41]. Indeed, a
majority of genomic CpG dinucleotides and 5-methyl
cytosines reside within ERVs and other retroelements in
mammals [42]. Several lines of evidence conﬁrm that genomic
hypomethylation and TE activation are interrelated. DNA
methyltransferase (Dnmt) mutant mice with mutant Dnmt1 or
Dnmt3 do not maintain and initiate methylation at existing or
new proviral loci, respectively [43,44]. In fact, both MLVs and
IAPs become substantially demethylated [43], and IAP
transcripts are expressed up to 100-fold higher in Dnmt1
/-
mice relative to wild-type [45]. While Dnmt1 is necessary after
DNA replication, Dnmt3a and Dnmt3b are essential in the
germ line and during development to establish the
DOI: 10.1371/journal.pgen.0020002.g001
Figure 1. Mutagenic Mechanisms of IAP and ETn Insertions
IAP and ETn insertions were classified by their mechanism of gene
disruption. Well documented instances of aberrant transcription
initiation (5’-terminus) and polyadenylation (3’-terminus) were counted,
as well as aberrant splicing and exon skipping (internal disruption).
Insertions that cause gene disruption by multiple mechanisms (Table S1)
were counted once in each relevant class.
DOI: 10.1371/journal.pgen.0020002.g002
Figure 2. Common Effects of ETn and IAP Insertions on Gene Expression
(A) ETn effects on gene transcript processing. The most common patterns of aberrant transcript processing caused by ETns in gene introns are shown.
The natural LTR polyadenylation (polyA) site and a second cryptic polyadenylation site in the internal region, along with four cryptic splice acceptors
(SA) and a donor site (SD), are involved in most cases. The number of such cases is an underestimate, since several reports lack sufficient detail of
aberrant transcripts. In some cases, several aberrant forms have been found. Boxes denote gene exons, thin lines denote introns, and thick lines denote
spliced mRNAs, with direction of transcription from left to right. For clarity, cryptic splice acceptor sites in the 3’ LTR are not shown since no
documented splicing events involving these sites were found. Intronic mutagenic ETns and the affected gene are most often found in the same
orientation (15 of 16 cases).
(B) IAP promoter effects on gene transcription. Ectopic gene expression driven by an antisense promoter in the 5’ LTR of an IAP has been reported in
eight cases. In some cases, the IAP is located a significant distance upstream of the gene.
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dispersed and tandem repeats [46]. Dnmt3a and Dnmt3b
knockout embryonic stem (ES) cells are unable to establish
methylation at new MLV integrations. Knockout ES cells and
embryos exhibit a general decrease in methylation at
centromere repeats, MLVs, IAPs, and L1s [44]. In addition to
theresearchonpromotermethylation,thereisastudyshowing
that intragenic methylation reduces the elongation efﬁciency
of RNA polymerase II [47], which suggests that the methylated
state of TEs within introns might affect gene expression.
It is well established that genomic methylation can serve to
recruit chromatin-remodeling proteins [41]. The SWI/SNF
family members are components of the trithorax group
protein complex and are responsible for maintaining
transcriptional activity. A SWI/SNF mammalian catalytic
subunit, Brm (SWI/SNF-related, matrix associated, actin-
dependent regulator of chromatin), is involved in increased
transcription of retroviral RNA, but this is alleviated in cells
lacking thisprotein [48]. Moreover, Brm-deﬁcient cellstreated
with histone deacetylase inhibitors are unable to silence
transcription of retroviral genes. These results suggest that
Brm-type SWI/SNF is essential for TE expression and that
histone deacetylation is crucial for silencing. Paradoxically,
Lsh (lymphoid-speciﬁc helicase), also a SWI/SNF family
member,preferentiallyassociateswithrepeatsandcontributes
to their silencing [49]. Lsh
/- mice are hyperacetylated at
histones overlying TEs (class I and II LTRs, LINEs, SINEs, and
centromeric repeats), and their transcripts are abundant. This
defect appears speciﬁc to repetitive sequences. A further level
of silencing is mediated by histone methylation. Intriguingly,
different families of repeats were found to have characteristic
repressive histone methylation patterns [50]. Furthermore,
histone methyltransferase knockout ES cells exhibited a loss of
Table 2. Mammalian Restriction Genes against Retroviral Activity
Species
a Gene Gene Function Time of Block Virus/Repeat Restricted References
h, ch, a, m APOBEC3 (g/f) Cytidine deaminase, RNA editing During RT HIV, SIV, MLV, IAP, MusD [66]
Mammals Dnmt1 Maintenance methylation (adult) Viral RNA expression IAP, MLV [42,44]
Mammals Dnmt1o Maintenance methylation (embryonic) Viral RNA expression IAP [116]
Mammals Dnmt3a De novo methylation (germ/ES cells), maternal/paternal imprinting Viral RNA expression MLV, L1, IAP [43,117]
Mammals Dnmt3b De novo methylation (ES cells/early embryos) Viral RNA expression MLV, L1, IAP, centromeric
repeats
[43]
Mammals Dnmt3l De novo methylation (spermatogonial precursors) Viral RNA expression IAP, LINE1 [118]
m Edg2 (Rec1) G-protein-coupled receptor Pre-infection Not available [61]
m Fv1 Endogenous gag-related, binds assembled virions
inducing dominant negative effect
Post-infection,
pre-integration
MLV [65]
m Mst1r (Fv2) C-met-related tyrosine kinase, limits target cell proliferation Post-infection Friend virus [119]
m Fv4 (Akvr) Endogenous env-related, binds cell receptors Pre-infection Ecotropic MLV [120]
m Fv5 Limitation of target cell proliferation Post-infection Friend virus [121]
m Lsh ATP-dependent chromatin-remodeling protein Viral RNA expression LTR ERVs, LINE, SINE, satellite [49]
m Nxf1 Nuclear export factor, role in correctly
processing pre-mRNAs possessing retroviral sequence
Post-integration IAP, MLV, LINE? [67]
Mammals Ref1/Lv1/Trim5 Poorly understood function affecting viral capsid Early post-entry HIV, SIV, MLV [68]
m Rfv1/2/3 Induction of cytotoxic T lymphocyte response Post-infection Friend virus [122,123]
m Rmcf Endogenous env-related, binds cell receptors Pre-infection Polytropic MLV [124]
m Rmv1/2/3 Role in antibody response against infection Post-infection MLV [125]
m Slc20a2 (Ram1) Cell membrane transporter proteins Pre-infection Exogenous amphotropic MLV [126]
m Xpr1 (Rmc1/Sxv) Xenotropic and polytropic retroviral receptor Pre-infection MLV [127]
Rodents ZAP Antiviral protein Viral RNA expression MLV [128]
Detailed information about each mouse locus and its orthologs can be found at http://www.informatics.jax.org.
aSpecies code: a, African green monkey; ch, chimpanzee; h, human; m, mouse.
DOI: 10.1371/journal.pgen.0020002.t002
DOI: 10.1371/journal.pgen.0020002.g003
Figure 3. Host Restriction and Silencing of ERVs/LTRs
Blocks to various stages of the retroviral or LTR retroelement life cycle are
depicted as are silencing mechanisms affecting activity of integrated
elements. Examples of restriction genes and silencing mechanisms:
receptor block, Fv4; uncoating block, Trim5; reverse transcription/
trafficking block, APOBEC3 and Fv1; transcription block, CpG methylation;
and RNA processing block, Nxf1 and RNAi. See text and Table 2 for more
details and other examples. An ERV or LTR element within an intron is
shown to illustrate common gene-disruptive effects of such sequences
through introduction of polyadenylation sites, promoters, and splice
donor and acceptor sites. Spliced RNA is depicted with dashed lines. A
normal gene transcript driven by the native promoter (P) is shown below
the gene. A full-length retroviral transcript, which could be packaged for
further rounds of retrotransposition or retroviral infection, is shown
above the gene locus. Various potential aberrant or chimeric transcripts
are shown above.
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tandem and interspersed repeats.
Post-transcriptional gene silencing. Since transcriptional
silencing is unlikely to prevent activity of all TEs, it is
essential that some processes act at the level of expressed
transcripts. An RNA interference (RNAi)–mediated
mechanism, the components of which are discussed elsewhere
[51], is involved in post-transcriptional gene silencing of
repetitive DNA. High levels of sense and antisense IAP and
ERV-L transcripts are expressed concurrently in developing
mice, but are not detected past the eight-cell stage [52,53].
Moreover, inhibiting the RNAi pathway in preimplantation
embryos by RNAi-mediated knockdown of Dicer results in a
50% increase in IAP and ERV-L transcripts [52,53]. Dicer
knockout mouse ES cells exhibit increased transcription from
centromeric repeats, L1s, and IAPs, combined with severe
developmental defects [54]. In an analogous example,
silencing of the mammalian X chromosome is dependent
upon an antisense transcript and shortly after its detection,
histone 3–lysine 9 and CpG methylation is established at Xist
[55], connecting double-stranded RNAs to transcriptional
gene silencing. The fact that heterochromatin can be
established at homologous loci via short interfering RNAs
(siRNAs) is well documented. Examples in model organisms
such as ﬁssion yeast and Arabidopsis have implicated repeat-
derived siRNAs in directing such conformational changes.
Fission yeast deleted for RNAi pathway components express
centromeric-repeat and integrated transgene transcripts,
normally heavily silenced by heterochromatinization [56].
Studies in plants show that TEs and tandem repeats
speciﬁcally become silenced by histone 3-lysine 9 and CpG
methylation. These changes are dependent on the chromatin
remodeling factor Decrease in DNA Methylation 1 (DDM1)
and guided by siRNAs. Indeed, various Arabidopsis genes
become subject to RNAi-mediated silencing because of TE
proximity to their promoters [57]. Similar results in human
cells have demonstrated that non TE-derived siRNAs targeted
to the EF1A promoter of a proviral green ﬂuorescent protein
reporter inhibits transcription of the transfected EF1A
promoter, as well as that of the endogenous copy [58]. Also,
siRNAs targeting the E-cadherin promoter induced DNA
methylation and heterochromatin [59], but DNA methylation
is not a prerequisite, as shown with the CDH1 promoter [60].
Host restriction factors. Finally, a variety of gene products,
some derived from domesticated viral genes, function at
various stages of the retroviral life cycle to curtail both
exogenous retroviruses and ERVs and have been extensively
reviewed recently [61–64] (Table 2). Some particularly
relevant examples include Fv1, the Ref/Lv1 family of proteins,
APOBEC3G, and Nxf1. Fv1, the ‘‘prototypic’’ retrovirus
restriction gene, is an ancient ERV-L gag-like gene that
restricts infection by MLV [65]. APOBEC3G encodes a cytidine
deaminase that mediates cysteine–uracil transitions when co-
packaged with retroviral genomes. It inhibits HIV and MLV
replication and also suppresses IAP and MusD/ETn
retrotransposition [66]. Nxf1, encoding an mRNA nuclear
export factor, has been shown to suppress the hypomorphic
effects of intronic IAP insertions, presumably by facilitating
accurate splicing [67]. The recently described Ref1/Lv1 family
of proteins, including TRIM5a, suppresses HIV and MLV
[68,69]. However, effects of these proteins on ERVs are
unknown.
Inbred Mice—Out of Balance with Their ERVs?
The evolution of silencing mechanisms by the host likely, in
turn, places pressure on TEs/ERVs to evolve means to escape
repression, setting up an ‘‘arms race,’’ not unlike that
involving the immune system and infectious agents [1,70,71].
In the case of TEs, waves of ampliﬁcation are countered by
host defenses (Figure 3) and negative selection that quench
activity until new variants or ‘‘master’’ elements appear that
are capable of instigating further genomic expansions [1,3].
The high rate of ERV germ line and somatic insertional
mutations in the laboratory mouse indicates that at least
some inbred strains are currently in an active phase of ERV
genomic expansion. In contrast, ERV-like elements in
humans, while present in comparable overall numbers, have
long ago ceased activity [7]. It is interesting to speculate which
is the more common situation in modern-day mammals.
Without detailed analysis of a variety of mammalian genomes
and mutational spectra, it is difﬁcult to answer this question.
In mouse, the still active ETn and IAP elements likely amplify
via intracellular retrotransposition, thereby avoiding the
‘‘front line’’ defense mechanisms, such as Fv1 and Fv4, in
place to inhibit early stages of exogenous infections. In
contrast, MLV likely ampliﬁes primarily through rounds of
infection of germ line cells, allowing more opportunities for
the host to evolve resistance and keep proviral copy number
low. We propose that inbred mice represent a relatively
transitory state in which host silencing mechanisms have not
yet adapted to retrotransposition of new ERV variants. The
IAP family nicely illustrates this point. The ID1 partly deleted
subtype is currently the most active IAP element but is a
minor fraction of the total number of existing IAPs. This
situation suggests that full-length IAPs ampliﬁed to high copy
numbers during mouse evolution but have recently been
essentially silenced. The ID1 subtype must have arisen
recently and, possibly because of speciﬁcs of its structure and/
or genomic context, has been freed from suppression and
allowed to retrotranspose—mainly in the C3H/HeJ strain. A
similar scenario is occurring with respect to ETn/MusD
elements, where a minor population of ETnII-b elements is
causing the bulk of current retrotranspositional activity. This
relatively permissive phase of ERV expansion that is ongoing
in inbred mice provides a rare opportunity to study how a
mammalian host genome responds to new waves of invasion
by mobile elements.
Conclusion
This review has attempted to highlight the mutational
impact that ERVs have had and continue to have on the
mouse germ line and to discuss host defenses that have
evolved to control these elements. Unlike in human, ERVs in
the mouse genome are in an expansion phase, with speciﬁc
IAP and ETn variants currently playing the dominant role.
These elements have accumulated to hundreds of copies in
the genome, but evidence indicates that only a few have a
high probability of retrotransposing. Identiﬁcation of their
genomic location and/or chromatin state may provide insight
into host control mechanisms and why particular elements
escape suppression. Genetic factors responsible for variable
retrotransposition rates in different strains also await
discovery and may reveal new host restriction genes or alleles.
Given the propensity for these ERVs to affect gene
PLoS Genetics | www.plosgenetics.org January 2006 | Volume 2 | Issue 1 | e2 0007expression, it would be interesting to investigate ERV
insertions as mediators of phenotypic differences among
inbred strains. Indeed, it may be particularly informative to
examine genes harboring polymorphic ERV insertions in
their introns.
The epigenetic control of mouse and human ERVs is of
substantial interest because of their potential effects on
adjacent genes. In addition to obvious gene-disruptive effects,
mammalian ERVs may also play a role in tissue-speciﬁc gene
regulation (see Box 4). Some IAP elements act as metastable
epialleles [38] with their methylation state determining
effects on neighboring genes. The idea that variable silencing
of retrotransposons could contribute to gene expression
variability in mammals [39] is attractive but, thus far, IAPs are
the only type of retroelement shown to display this effect, and
it remains to be determined how widespread this
phenomenon may be. Functions for RNA-mediated silencing,
including potential roles for RNAi [53] and microRNAs [72]
in controlling ERVs and exogenous retroviruses, are rapidly
being elucidated. A number of questions, however, including
the origins of double-stranded RNA necessary for inducing
silencing, are currently unanswered [73].
Although ERV insertions are not a source of new mutations
in humans, understanding their effects in mice is important
for understanding gene regulatory effects of existing human
ERVs/LTRs, thousands of which are located within gene
borders [74,75], and in elucidating the disruptive effects of
therapeutic retroviral vectors. Retroviral activation of proto-
oncogenes has occurred in gene therapy trials, raising major
concerns [76]. Therefore, potential long-range promoter or
enhancer effects, as displayed by IAP elements, need to be
considered and vectors designed to reduce the chances of
oncogene activation [77]. The high probability of some
retroviruses integrating into introns [78,79] may also limit
their usefulness as therapeutic gene delivery systems if
aberrant gene splicing and polyadenylation results.
Eliminating cryptic splicing and polyadenylation signals
within retroviral vectors may be a worthwhile strategy.
However, as demonstrated by the mouse ERVs, unique
properties and sequence motifs result in distinct mutational
mechanisms (see Figure 1), indicating the challenge of
attempting to predict a priori the mutagenic behavior of
different classes of retroviruses.
Supporting Information
Table S1. Germ Line Mouse Mutations Caused by ERV Insertions
Found at DOI: 10.1371/journal.pgen.0020002.st001 (233 KB DOC).
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